Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Target Organs and Levels of Evidence for TR-548

Toxicology and Carcinogenesis Studies of Ethinyl Estradiol (CASRN 57-63-6) in Sprague-Dawley Rats (Feed Studies)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
Endocrine disruptor (Ethinyl estradiol) 57-63-6	05/16/2007	Dosed-Feed 0, 2, 10, or 50 ppb	National Center for Toxicological Research

Levels of Evidence

F1C Male Rats: No Evidence

Type	Organ/Tissue (Lesion)
Non-Neoplastic Lesions	Mammary Gland: alveolar hyperplasia (1/44, 4/45, 6/47, 18/44); ductal hyperplasia (0/44, 0/45, 2/47, 3/44) Liver: basophilic focus (1/49, 3/49, 3/50, 17/49); eosinophilic focus (3/49, 5/49, 8/50, 15/49)

F1C Female Rats: No Evidence

Type	Organ/Tissue (Lesion)
Non-Neoplastic Lesions	Uterus: endometrial hyperplasia (17/51, 18/50, 22/49, 25/50); squamous metaplasia (2/51, 6/50, 8/49, 13/50); atypical focal hyperplasia (6/51, 14/50, 16/49, 20/50) Liver: eosinophilic focus (1/51, 1/50, 1/49, 5/50)

Levels of Evidence

F1T140 Male Rats: No Evidence

Type	Organ/Tissue (Lesion)
Non-Neoplastic Lesions	Liver: basophilic focus (1/49, 3/50, 11/48, 6/49); eosinophilic focus (3/49, 11/50, 5/48, 10/49) Mammary gland: alveolar hyperplasia (1/44, 2/45, 6/47, 14/48); ductal hyperplasia (0/44, 0/45, 1/47, 3/48)

F1T140 Female Rats: Equivocal Evidence

Type	Organ/Tissue (Lesion)
May Have Been Related	Uterus: stromal polyp (2/51, 5/50, 6/50, 7/50)
Non-Neoplastic Lesions	Liver: basophilic focus (1/51, 1/50, 1/50, 6/50) Clitoral Gland: hyperplasia (2/50, 1/50, 2/49, 8/49)

Levels of Evidence

F3T21 Male Rats: Equivocal Evidence

Type	Organ/Tissue (Lesion)
May Have Been Related	Mammary Gland: adenoma or adenocarcinoma (0/42, 0/42, 0/40, 3/45) Preputial Gland: epithelial neoplasms (2/49, 4/49, 4/50, 8/49)
Non-Neoplastic Lesions	Mammary Gland: alveolar hyperplasia (2/42, 6/42, 4/40, 9/45)

F3T21 Female Rats: Equivocal Evidence

Type	Organ/Tissue (Lesion)
May Have Been Related	Uterus: stromal polyp (1/52,7/50, 2/50, 5/50)
Non-Neoplastic Lesions	Clitoral Gland: hyperplasia (0/50, 1/50, 2/49, 3/48) Uterus: squamous metaplasia (1/52, 4/50, 3/50, 11/50); atypical focal hyperplasia (6/52, 16/50, 15/50, 21/50)